Keywords: roche, drug, combo, helps, pegintron-resistant, patients, swiss
Roche drug combo helps Pegintron-resistant patients
Article | 21 November 2007
Swiss drug major Roche says that final results from the REPEAT study demonstrate that treatment with once-weekly Pegasys (peginterferon alfa-2 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
